Estrogen and Selective Estrogen Receptor Modulators: Neuroprotection in the Women's Health Initiative Era

By Murphy Stephanie J.   McCullough Louise D.   Littleton-Kearney Marguerite T.   Hurn Patricia D.  

Endocrine Journal, Vol. 21, Iss. 1, 2003-06 ,pp. : 17-26

Humana Press, Inc

Access to resources Recommend Favorite

Estrogen plus progestin and the risk of coronary heart disease

By Manson J.E.   Hsia J.   Johnson K.C.   for the Women's Health Initiative Investigators  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 24-24

Elsevier

Access to resources Recommend Favorite

Effects of Raloxifene, One of the Selective Estrogen Receptor Modulators, on Pituitary–Ovary Axis and Prolactin in Postmenopausal Women

By Cheng Wern-Cherng   Yen Men-Lu   Hsu Sandy H. J.   Chen Kuang-Ho   Tsai Keh-Sung  

Endocrine Journal, Vol. 23, Iss. 2-3, 2004-03 ,pp. : 215-218

Humana Press, Inc

Access to resources Recommend Favorite

Hormone Replacement Therapy, Selective Estrogen Receptor Modulators, and Tissue-Specific Compounds: Cardiovascular Effects and Clinical Implications

By Vogelvang Tatjana E.   Marius J. van der Mooren   Mijatovic Velja  

Treatments in Endocrinology, Vol. 3, Iss. 2, 2004-01 ,pp. : 105-115

Adis International

Access to resources Recommend Favorite

Leukocytes and coronary heart disease

By Hoffman M.   Blum A.   Baruch R.   Kaplan E.   Benjamin M.  

Atherosclerosis, Vol. 172, Iss. 1, 2004-01 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite